H2020FP7HORIZON
Janssen Vaccines & Prevention BV
- Country
- NLNetherlands
- Defence projects
- 0
- Projects, all programmes
- 16
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 1,766,026
- Active
- 2012 to 2023
Projects
16 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| iAdsIntelligent design of adenovirus vectors (iAds) | HORIZON | 2023 | Participant | EUR 531,169 |
| ReCHISVacExperimental vaccinology, revealing unnatural signatures of protection by repeat controlled human schistosome infection. | HORIZON | 2022 | Associated partner | EUR 0 |
| PrIMAVeRaPredicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance | H2020 | 2021 | Participant | EUR 0 |
| INITIATEINnate-ImmunomeTabolIsm as Antiviral TargEt | H2020 | 2019 | Participant | EUR 265,620 |
| VITALVaccines and Infectious Diseases in the Ageing PopuLation | H2020 | 2019 | Participant | EUR 0 |
| EBOVAC3Bringing a prophylactic Ebola vaccine to licensure | H2020 | 2018 | Participant | EUR 0 |
| OptiMalVaxOptimizing a deployable high efficacy malaria vaccine | H2020 | 2017 | Participant | EUR 25,000 |
| EDGETraining network providing cutting-EDGE knowlEDGE on Herpes Virology and Immunology | H2020 | 2016 | Participant | EUR 255,374 |
| EHVAEuropean HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates | H2020 | 2016 | Participant | EUR 34,845 |
| FLUCOPStandardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protection | FP7 | 2015 | Participant | Not stated |
| EBOVAC1Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen – Sofia ref.: 115854 | H2020 | 2014 | Participant | EUR 0 |
| EBOMANManufacturing and Development for Rapid Access Ebola Vaccine (EBOMAN) – Sofia ref.: 115850 | H2020 | 2014 | Participant | EUR 0 |
| EBOVAC2Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II - Sofia ref.: 115861 | H2020 | 2014 | Participant | EUR 0 |
| ADVANCEAccelerated Development of Vaccine benefit-risk Collaboration in Europe | FP7 | 2013 | Participant | Not stated |
| AD-VECAdenovirus Vector Technology: Next Generation Systems for Medical Therapy | FP7 | 2013 | Participant | EUR 336,242 |
| ADVANCEADenoViruses as novel clinical treatments | FP7 | 2012 | Participant | EUR 317,777 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.